| Mark Antyn Griffith, | |
|
6000 Executive Blvd, Ste 602, Rockville, MD 20852-3820 | |
| (301) 770-6301 | |
| Not Available |
| Full Name | Mark Antyn Griffith |
|---|---|
| Gender | Male |
| Speciality | Pain Medicine - Pain Medicine |
| Location | 6000 Executive Blvd, Rockville, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275221285 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | R200261 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark Antyn Griffith, 6000 Executive Blvd Ste 602, Rockville, MD 20852-3820 Ph: (301) 770-6301 | Mark Antyn Griffith, 6000 Executive Blvd, Ste 602, Rockville, MD 20852-3820 Ph: (301) 770-6301 |
News Archive
Researchers recently conducted a study to identify host factors affecting cellular interactions of the SARS-CoV-2 spike protein.
Put patients first. That's what Mr Reid says. That's fine. Consultants do this every day. We don't need a politician to say it, like it's something we never thought of. When a consultant is working 50 hours a week despite only being paid for 35, that is putting the patient first. When a consultant is operating on an emergency patient in the middle of the night, that is putting the patient first.
Miracle Applications Corp. is proud to announce it has entered into a Licensing Agreement with Bioflex Medical Magnetic Inc. to sell and market select Bioflex products. The Bioflex magnet is clinically proven to reduce pain, accelerate healing and improve circulation. Bioflex Medical Magnetic Inc. was formed in October, 1986 and BIOflex® Concentric Circle Magnet is the original magnet for human use.
Patients with kidney cancer who had their entire organ removed were more likely to have more renal complications and poorer health after surgery, compared to those who had only part of their kidney removed, a study has shown.
Combining intratumoral electroporation of interleukin-12 (IL-12) DNA (tavokinogene telseplasmid, or TAVO) with the immune checkpoint inhibitor pembrolizumab (Keytruda) led to clinical responses in patients with immunologically quiescent advanced melanoma, according to results from a phase II trial.
› Verified 2 days ago
Dr. Prabaal B Dey, M.D. Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 11921 Rockville Pike, Ste 505, Rockville, MD 20852 Phone: 410-265-7300 Fax: 410-265-9533 | |
Dr. Marc Alexander Loev, MD Pain Medicine Medicare: Medicare Enrolled Practice Location: 11921 Rockville Pike, Suite 505, Rockville, MD 20852 Phone: 301-881-7246 Fax: 301-881-2449 | |
Dr. Lester Alan Zuckerman, M.D. Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 11921 Rockville Pike, Suite 505, Rockville, MD 20852 Phone: 301-881-7246 Fax: 301-881-2449 | |
Dr. Bernard Emmett Filner, M.D. Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 15005 Shady Grove Rd, #320, Rockville, MD 20850 Phone: 301-251-1266 Fax: 301-279-8680 |